Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Study ID: NCT06559189
Start Date: 2024-09-27
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

26

Intervention / Treatment

CD19x22 CAR T

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Study ID: NCT06823167
Start Date: 2025-02-26
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

117

Intervention / Treatment

IM-1021

Sponsor

Immunome, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Study ID: NCT04676360
Start Date: 2021-07-01
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Mafodotin Belantamab

Sponsor

Jacob Soumera, MD

Source: clinicaltrials.gov

Share:
Add to list

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

Study ID: NCT05923060
Start Date: 2024-08-25
End Date: 2025-05-22
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Topical Aminolevulinate

Photodynamic therapy (PDT)

Red light illumination

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Study ID: NCT04417660
Start Date: 2020-12-26
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

44

Intervention / Treatment

4

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

Study ID: NCT05448560
Start Date: 2023-01-01
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Multi-level Intervention of shared model of survivorship care

Comparison Group

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list

Metformin for the Prevention of Oral Cancer in Patients with Oral Leukoplakia or Erythroplakia

Study ID: NCT05237960
Start Date: 2023-01-12
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Biopsy

Biospecimen Collection

Extended Release Metformin Hydrochloride

Placebo Administration

Sponsor

University of Arizona

Source: clinicaltrials.gov

Share:
Add to list

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Study ID: NCT06323460
Start Date: 2024-03-21
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

External Beam Radiation Therapy

Paclitaxel

Positron Emission Tomography

Administration questionnaire

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells with or Without Naxitamab (Danyelza) for the Treatment of Patients with Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Study ID: NCT06026657
Start Date: 2024-04-02
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

42

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Gemcitabine

Magnetic Resonance Imaging

NAXITAMAB

Universal Donor Expanded TGF-beta-imprinted NK Cells

Sponsor

Margaret Gatti-Mays

Source: clinicaltrials.gov

Share:
Add to list

PSMA PET Response Guided SabR in High Risk Pca

Study ID: NCT06044857
Start Date: 2024-03-07
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

68ga PSMA 11

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list